Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients (Q39572838)

13 September 2017

Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients (English)

1 reference

13 September 2017

0 references

5

Lone Hummelshoj

1 reference

13 September 2017

Kyle A Serikawa

1

1 reference

13 September 2017

Søren Jacobsen

2

1 reference

13 September 2017

Dorthe Lundsgaard

3

1 reference

13 September 2017

Brian A Fox

4

1 reference

13 September 2017

Lars K Poulsen

6

1 reference

13 September 2017

Jan Fleckner

7

1 reference

13 September 2017

Klaus Stensgaard Frederiksen

8

1 reference

13 September 2017

8 August 2012

1 reference

13 September 2017

1 reference

13 September 2017

23

1 reference

13 September 2017

729-740

1 reference

13 September 2017

4

1 reference

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

13 September 2017

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Use of a genomic test (MammaPrint™) in daily clinical practice to assist in risk stratification of young breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

A novel, quantitative bioassay for type I interferon using a recombinant indicator cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Type I interferon in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Convergent Random Forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

Cutting edge: FcR-like 5 on innate B cells is targeted by a poxvirus MHC class I-like immunoevasin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-012-0723-9

10.3109/S10165-012-0723-9

21 January 2018

Identifiers

DOI

1 reference

release_mli43t2chvallfia2xxgkkixqe

13 September 2017

0 references

1 reference